SCHEMBL7308065

SCHEMBL7308065

COC(=O)C(NC(=O)N1CCN(C)CC1)C(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
HSD17B10 Q99714 1/20 0.51
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.41
CA12 O43570 1/20 0.41
CA14 Q9ULX7 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
CACNA1H O95180 2/20 0.38
PKM P14618 1/20 0.38
EPHX2 P34913 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7279963 1.00 MEN1 (0.52) MEN1KMT2AHSD17B10TP53POLB
SCHEMBL6447920 0.83 KDM4E (0.43) MEN1KMT2APOLBSMN1; SMN2CYP1A2
SCHEMBL5711205 0.83 KDM4E (0.43) MEN1KMT2APOLBSMN1; SMN2CYP1A2
SCHEMBL7339511 0.82 PKM (0.60) MEN1KMT2AHSD17B10TSHRSMN1; SMN2
SCHEMBL7339518 0.82 PKM (0.60) MEN1KMT2AHSD17B10TSHRSMN1; SMN2
SCHEMBL31618840 0.82 MEN1 (0.51) MEN1KMT2AHSD17B10POLBTSHR
Lithium SCHEMBL7270041 0.81 KDM4E (0.42) MEN1KMT2APOLBSMN1; SMN2CYP1A2
SCHEMBL7270034 0.81 KDM4E (0.42) MEN1KMT2APOLBSMN1; SMN2CYP1A2
Lithium Ion SCHEMBL7270031 0.80 CYP1A2 (0.38) MEN1KMT2AHSD17B10POLBSMN1; SMN2
SCHEMBL8746954 0.79 KDM4E (0.43) MEN1KMT2APOLBSMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed